New micro-laparoscopic instruments offer surgeons less invasive option for patients
Becton, Dickinson and Company (BD) has announced that its new line of Snowden-Pencer 3.0mm laparoscopic ergonomic take-apart instruments received FDA 510(k) clearance for use in laparoscopic surgery. The new line of Snowden-Pencer 3.0mm laparoscopic ergonomic take-apart instruments are designed for micro-laparoscopic surgery and function like 5.0mm instruments. The jaw lengths of the devices mirror those of standard laparoscopic instruments, providing surgeons with a less invasive approach without compromising instrument functionality.
The launch of this new line enables BD to offer one of the most customisable portfolios of 3.0mm micro-laparoscopic instruments available. It offers 26 different jaw patterns, two different lengths (24cm, 36cm) and six-take-apart handles, resulting in 312 combinations to target procedures in multiple specialties.
The micro-laparoscopic devices are also compatible with an interchangeable modular system that includes the standard Snowden-Pencer 5.0mm and 10.0mm laparoscopic instruments.
The new Snowden-Pencer micro-laparoscopic instrument is used in procedures known to provide patients with a virtually scar-less procedure, reduce post-operative pain, improve post-operative appearance and reduce hospital stays, the company claims.
“Minimally invasive micro-laparoscopic surgery is a steadily growing field resulting from patient demand for less invasive surgical options and scar reduction,” said Jim Leitl, worldwide vice president and general manager of Infection Prevention, V Mueller and Interventional Specialties for BD. “This innovative new line of instruments enables providers to choose the best surgical option for their patients.”
The new line of micro-laparoscopic devices is the latest in BD’s line of take-apart surgical instruments that are designed for easy assembly and disassembly to support sterility initiatives and are engineered to withstand demanding sterile processing techniques.